A conserved role for the ALS-linked splicing factor SFPQ in repression of pathogenic cryptic last exons

SFPQ is a splicing factor and its mutations are associated to amyotrophic lateral sclerosis (ALS) patients. Here, the authors show that SFPQ represses the use of pathogenic cryptic last exons in zebrafish, mouse and human cells.

Guardado en:
Detalles Bibliográficos
Autores principales: Patricia M. Gordon, Fursham Hamid, Eugene V. Makeyev, Corinne Houart
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/dbf009023d6d49ffada9dbd438aaf6be
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!